They are promising alternatives to other traditional viral vectors, such as Adenovirus and Lentivirus vectors. This is because rAAVs have low immunogenicity and can exhibit long-term gene expression, ...

Oxford Biomedica rebrands as OXB reinforcing transformation into leading global cell and gene therapy CDMO Oxford, UK – 18 ...

They can employ either recombinant viruses, such as adenovirus, adeno-associated virus (AAV), retrovirus, or lentivirus, or non-viral platforms, such as lipid nanoparticles, to transport the chosen ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Labroots and the Cell & Gene Therapy planning committee are thrilled to announce the debut of the Cell & Gene Therapy Virtual Event Series, premiering exclisively online October 16th, 2024. Join us as ...

In this thought leader article Orjana Terova, Melisa Carpio, Ian Flaherty, Robin Butler, Nico Tuason, and Christine Gebski from Repligen describe how disruptive technologies are improving efficiency ...

Download this application note from Thermo Fisher Scientific to learn how scientists have used their lentiviral production system, single-use bioreactors, and clarification products to generate ...

Revised: This Reviewed Preprint has been revised by the authors in response to the previous round of peer review; the eLife assessment and the public reviews have been updated where necessary by the ...

The inhibition of ERK5 is a potential complementary strategy for countering FAK inhibitor resistance in patients with lung ...